terfenadine has been researched along with Basal Cell Cancer in 1 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernández-Nogueira, P | 1 |
| Noguera-Castells, A | 1 |
| Fuster, G | 1 |
| Recalde-Percaz, L | 1 |
| Moragas, N | 1 |
| López-Plana, A | 1 |
| Enreig, E | 1 |
| Jauregui, P | 1 |
| Carbó, N | 1 |
| Almendro, V | 1 |
| Gascón, P | 1 |
| Bragado, P | 1 |
| Mancino, M | 1 |
1 other study available for terfenadine and Basal Cell Cancer
| Article | Year |
|---|---|
Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Resistance, Neo | 2018 |